422 related articles for article (PubMed ID: 23790570)
21. Albumin: Indications in chronic liver disease.
Tufoni M; Zaccherini G; Caraceni P; Bernardi M
United European Gastroenterol J; 2020 Jun; 8(5):528-535. PubMed ID: 32213034
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of cirrhotic complications with human serum albumin].
Henriksen JH; Ring-Larsen H
Ugeskr Laeger; 2005 Jan; 167(4):414. PubMed ID: 15719571
[No Abstract] [Full Text] [Related]
23. [Use of albumin : State of the art].
Mayerhöfer T; Wiedermann CJ; Joannidis M
Med Klin Intensivmed Notfmed; 2021 Nov; 116(8):655-664. PubMed ID: 34618163
[TBL] [Abstract][Full Text] [Related]
24. Human serum albumin: from bench to bedside.
Fanali G; di Masi A; Trezza V; Marino M; Fasano M; Ascenzi P
Mol Aspects Med; 2012 Jun; 33(3):209-90. PubMed ID: 22230555
[TBL] [Abstract][Full Text] [Related]
25. [Current role of albumin in critical care].
Aguirre Puig P; Orallo Morán MA; Pereira Matalobos D; Prieto Requeijo P
Rev Esp Anestesiol Reanim; 2014 Nov; 61(9):497-504. PubMed ID: 24952825
[TBL] [Abstract][Full Text] [Related]
26. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
27. Review article: Management of ascites and associated complications in patients with cirrhosis.
Kuiper JJ; de Man RA; van Buuren HR
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
[TBL] [Abstract][Full Text] [Related]
28. Albumin infusion in liver cirrhotic patients.
Rena NM; Wibawa ID
Acta Med Indones; 2010 Jul; 42(3):162-8. PubMed ID: 20724771
[TBL] [Abstract][Full Text] [Related]
29. [Albumin substitution : A review of the indications in general internal medicine].
Dumas D; Benmachiche M; Gachoud D
Rev Med Suisse; 2021 Nov; 17(760):2022-2026. PubMed ID: 34817939
[TBL] [Abstract][Full Text] [Related]
30. Management of ascites in the patient with portal hypertension with emphasis on spontaneous bacterial peritonitis.
Navasa M; Rodés J
Semin Gastrointest Dis; 1997 Oct; 8(4):200-9. PubMed ID: 9360284
[TBL] [Abstract][Full Text] [Related]
31. Albumin Substitution in Decompensated Liver Cirrhosis: Don't Forget Zinc.
Grüngreiff K; Gottstein T; Reinhold D; Blindauer CA
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836265
[TBL] [Abstract][Full Text] [Related]
32. [Advances in therapy for ascites and hepatorenal syndrome].
Gerbes AL; Gülberg V
Z Gastroenterol; 2005 Jan; 43(1):31-4. PubMed ID: 15650969
[TBL] [Abstract][Full Text] [Related]
33. Fluid retention in cirrhosis: pathophysiology and management.
Kashani A; Landaverde C; Medici V; Rossaro L
QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
[TBL] [Abstract][Full Text] [Related]
34. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
[TBL] [Abstract][Full Text] [Related]
35. Moderator Effect of Hypoalbuminemia in Volume Resuscitation and Plasma Expansion with Intravenous Albumin Solution.
Wiedermann CJ
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430652
[TBL] [Abstract][Full Text] [Related]
36. Balancing volume resuscitation and ascites management in cirrhosis.
Polli F; Gattinoni L
Curr Opin Anaesthesiol; 2010 Apr; 23(2):151-8. PubMed ID: 20124894
[TBL] [Abstract][Full Text] [Related]
37. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
Karwa R; Woodis CB
Ann Pharmacother; 2009 Apr; 43(4):692-9. PubMed ID: 19299324
[TBL] [Abstract][Full Text] [Related]
38. Management of cirrhotic ascites in children: Review and recommendations. Part 2: Electrolyte disturbances, nonelectrolyte disturbances, therapeutic options.
Bes DF; Cristina Fernández M; Malla I; Repetto HA; Buamscha D; López S; Martinitto R; Cuarterolo M; Alvarez F
Arch Argent Pediatr; 2017 Oct; 115(5):505-511. PubMed ID: 28895701
[TBL] [Abstract][Full Text] [Related]
39. Controversies Surrounding Albumin Use in Sepsis: Lessons from Cirrhosis.
Wiedermann CJ
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139434
[TBL] [Abstract][Full Text] [Related]
40. Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
Møller S; Aagaard NK; Schmidt L; Grønbaek H; Hansen JB; Bendtsen F
Dan Med J; 2012 Jan; 59(1):C4372. PubMed ID: 22239848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
